(EN) The invention relates to a substituted aminopropionate compound shown as a formula I, pharmaceutically acceptable salt and/or solvate and/or hydrate thereof, and a pharmaceutical composition containing the compound, wherein the substituted aminopropionate compound is used for treating infection caused by SARS-CoV-2.
(ZH) 本发明涉及式I所示取代氨基丙酸酯类化合物,及其药学上可接受的盐和/或其溶剂化物和/或其水合物,及含有此化合物的药物组合物,用于治疗SARS‑CoV‑2引起的感染。